Treatment for Mosquito Repellent Ingestion
For ingestion of mosquito repellent containing DEET or picaridin, immediately wash the mouth/skin if contaminated, provide supportive care with close monitoring for neurological symptoms (especially in children), and manage aspiration pneumonitis if it develops—most cases require only observation and dilution, but children who ingest DEET may develop seizures and encephalopathy requiring aggressive supportive management.
Immediate Management
Decontamination
- Wash the mouth and any contaminated skin immediately 1
- Do NOT induce vomiting (risk of aspiration)
- Provide dilution with water or milk for oral ingestion
- Irrigation is the primary treatment modality 2
Risk Stratification by Product Type
DEET-containing products:
- Higher risk of neurotoxicity, particularly in children
- Even low doses (80 mg/kg) can cause severe encephalopathy in small children 3
- Symptoms can appear within 2 hours of ingestion 3
- Watch for: seizures, coma, altered mental status, toxic encephalopathy 1, 3
Picaridin-containing products:
- Generally associated with minor toxicity only 2
- 92.9% of exposures managed outside healthcare facilities 2
- No reported deaths or major effects in NPDS data 2
- Primary symptoms: oral irritation, vomiting, ocular irritation 2
Liquid mosquito repellents (hydrocarbon-based with pyrethroids):
- Primary concern is aspiration pneumonitis, not neurological toxicity 4
- 70% develop mild-moderate ARDS requiring oxygen 4
- Symptoms typically appear after mean 6-hour interval 4
Clinical Monitoring
Neurological Assessment (Priority for DEET)
Monitor closely for:
- Altered mental status or decreased level of consciousness
- Seizure activity (most common serious complication with DEET) 3
- Signs of encephalopathy
- Onset typically within 2 hours but can be delayed 3
Respiratory Assessment (Priority for hydrocarbon-based products)
- Assess for signs of aspiration: cough, dyspnea, hypoxia
- Chest examination for crackles/decreased breath sounds
- Consider chest X-ray if respiratory symptoms develop 4
Supportive Treatment
For DEET neurotoxicity:
- Seizure management with benzodiazepines as first-line
- Airway protection if altered mental status
- Supportive care in monitored setting
- Most patients recover without sequelae if managed appropriately 3
For aspiration pneumonitis:
- Supplemental oxygen as needed
- Positive airway pressure support if moderate-severe ARDS develops 4
- Average duration of oxygen requirement: 3.3 days 4
- Antibiotics NOT routinely indicated unless secondary bacterial infection develops
For minor exposures (especially picaridin):
- Observation at home is appropriate for most cases 2
- Symptomatic treatment: antiemetics for vomiting, oral care for irritation
- Most resolve with dilution/irrigation alone 2
Disposition Criteria
Admit to hospital if:
- Any neurological symptoms (DEET exposure)
- Respiratory distress or hypoxia
- Large volume ingestion
- Age <2 years with DEET exposure (higher risk of severe toxicity) 3
- Symptoms developing or worsening
Discharge home if:
- Picaridin exposure with no or minimal symptoms after 4-6 hours observation
- Small accidental ingestion with normal examination
- Reliable caregiver for monitoring
- Clear return precautions provided
Critical Pitfalls to Avoid
Underestimating DEET toxicity in children: Even "low doses" can cause severe encephalopathy—maintain high index of suspicion 3
Confusing product types: Liquid mosquito repellents cause primarily respiratory (aspiration) complications, while DEET causes neurological toxicity 4
Delayed presentation: Symptoms may not appear for several hours, particularly with hydrocarbon aspiration 4
Assuming all repellents are equally benign: DEET has significantly higher neurotoxicity risk compared to picaridin 2, 3
The evidence strongly supports that picaridin exposures are generally benign with 92.9% managed outside healthcare facilities and no deaths reported 2, while DEET exposures, particularly in children, require more aggressive monitoring and management due to risk of severe neurotoxicity even at relatively low doses 3.